Literature DB >> 29054324

Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins.

André T R Goes1, Cristiano R Jesse2, Michelle S Antunes1, Fernando V Lobo Ladd3, Aliny A B Lobo Ladd4, Cristiane Luchese5, Natalia Paroul6, Silvana P Boeira1.   

Abstract

Chrysin is a natural flavonoid which is found in bee propolis, honey and various plants, and neuroprotective effect of chrysin in mice was previously demonstrated by our group. Neuroinflammation, neurotrophic factors and neuronal recovery factors associated with the neuroprotective effect of this flavonoid require further investigations. Thus, now we investigated the possible involvement of inflammatory cytokines, neurotrophic factors and neuronal recovery in the effect of chrysin in 6-hydroxidopamine (6-OHDA), a well-established model of Parkinson's disease, in striatum of mice. The 6-OHDA microinjection induced behavioral alterations on the rotarod test and apomorphine-induced circling behavior in mice. 6-OHDA administration elevated levels of tumour necrosis factor-α, interferon-gamma, interleukin-1β, interleukin-2, interleukin-6 and nuclear factor-kappa B and decreased the interleukin-10 levels, total reactive antioxidant potential and total antioxidant reactivity in striatum, as well as, modified the calcium-binding protein B (S100B), brain-derived neurotrophic factor, nerve growth factor and glial cell line-derived neurotrophic factor levels. The intrastriatal injection of 6-OHDA also induced an decrease of dopamine, 3,4-dihydroxyphenylacetic acid, homovanylic acid levels and tyrosine hydroxylase content. Oral treatment with chrysin (10 mg/kg, 28 days), culminated with the prevention of these alterations occasioned by 6-OHDA. These results corroborated with the neuroprotective effect of chrysin in the treatment of Parkinson's disease and, indicated the mechanism involved throught the inflammatory cytokines, neurotrophic factors and recovery of dopaminergic neurons in striatum.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dopamine; Flavonoid; Inflammation; Neurodegenerative disease; Neurotrophic factor

Mesh:

Substances:

Year:  2017        PMID: 29054324     DOI: 10.1016/j.cbi.2017.10.019

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  26 in total

Review 1.  Emerging role of S100B protein implication in Parkinson's disease pathogenesis.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

2.  Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.

Authors:  Michelle S Antunes; Fernando Vagner Lobo Ladd; Aliny Antunes Barbosa Lobo Ladd; Amanda Lopez Moreira; Silvana Peterini Boeira; Leandro Cattelan Souza
Journal:  Metab Brain Dis       Date:  2020-10-15       Impact factor: 3.584

3.  Unraveling the Mechanisms Underlying Irregularities in Inspiratory Rhythm Generation in a Mouse Model of Parkinson's Disease.

Authors:  Luiz M Oliveira; Nathan A Baertsch; Thiago S Moreira; Jan-Marino Ramirez; Ana C Takakura
Journal:  J Neurosci       Date:  2021-04-16       Impact factor: 6.167

Review 4.  Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.

Authors:  Jelena Osmanovic Barilar; Ana Knezovic; Ana Babic Perhoc; Jan Homolak; Peter Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2020-02-06       Impact factor: 3.575

5.  Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease.

Authors:  Mikhail V Voronin; Ilya A Kadnikov; Dmitry N Voronkov; Sergey B Seredenin
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 6.  Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.

Authors:  Roxana Braga de Andrade Teles; Tâmara Coimbra Diniz; Tiago Coimbra Costa Pinto; Raimundo Gonçalves de Oliveira Júnior; Mariana Gama E Silva; Érica Martins de Lavor; Antonio Wilton Cavalcante Fernandes; Ana Paula de Oliveira; Fernanda Pires Rodrigues de Almeida Ribeiro; Amanda Alves Marcelino da Silva; Taisy Cinthia Ferro Cavalcante; Lucindo José Quintans Júnior; Jackson Roberto Guedes da Silva Almeida
Journal:  Oxid Med Cell Longev       Date:  2018-05-10       Impact factor: 6.543

7.  Propolis as A Potential Disease-Modifying Strategy in Parkinson's Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model.

Authors:  Valeria C Gonçalves; Daniel J L L Pinheiro; Tomás de la Rosa; Antônio-Carlos G de Almeida; Fúlvio A Scorza; Carla A Scorza
Journal:  Nutrients       Date:  2020-05-26       Impact factor: 5.717

8.  Chrysin Attenuates the NLRP3 Inflammasome Cascade to Reduce Synovitis and Pain in KOA Rats.

Authors:  Taiyang Liao; Liang Ding; Peng Wu; Li Zhang; Xiaochen Li; Bo Xu; Haosheng Zhang; Zhenyuan Ma; Yancheng Xiao; Peimin Wang
Journal:  Drug Des Devel Ther       Date:  2020-07-28       Impact factor: 4.162

Review 9.  Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease.

Authors:  Paulina Troncoso-Escudero; Alejandra Parra; Melissa Nassif; Rene L Vidal
Journal:  Front Neurol       Date:  2018-10-15       Impact factor: 4.003

Review 10.  Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects?

Authors:  Fei-Xuan Wang; Hong-Yan Li; Yun-Qian Li; Ling-Dong Kong
Journal:  Biomolecules       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.